Clone Algo Technologies Performance

CATIDelisted Stock  USD 300.00  0.00  0.00%   
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Clone Algo are completely uncorrelated.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Clone Algo Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Clone Algo is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders. ...more
  

Clone Algo Relative Risk vs. Return Landscape

If you would invest  30,000  in Clone Algo Technologies on October 11, 2025 and sell it today you would earn a total of  0.00  from holding Clone Algo Technologies or generate 0.0% return on investment over 90 days. Clone Algo Technologies is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Clone, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  

Clone Algo Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Clone Algo's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Clone Algo Technologies, and traders can use it to determine the average amount a Clone Algo's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

High ReturnsBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
CATI
Based on monthly moving average Clone Algo is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Clone Algo by adding Clone Algo to a well-diversified portfolio.

Clone Algo Fundamentals Growth

Clone Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Clone Algo, and Clone Algo fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Clone Pink Sheet performance.

About Clone Algo Performance

By evaluating Clone Algo's fundamental ratios, stakeholders can gain valuable insights into Clone Algo's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Clone Algo has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Clone Algo has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Clone Algo Technologies Inc., a technology company, develops algorithms and risk management systems based on artificial intelligence. Clone Algo Technologies Inc. was founded in 2013 and is based in Chapel Hill, North Carolina. Clone Algo is traded on OTC Exchange in the United States.

Things to note about Clone Algo Technologies performance evaluation

Checking the ongoing alerts about Clone Algo for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Clone Algo Technologies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Clone Algo is not yet fully synchronised with the market data
Clone Algo has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 305 K. Net Loss for the year was (84.07 K) with profit before overhead, payroll, taxes, and interest of 0.
Clone Algo Technologies currently holds about 2.08 M in cash with (70.39 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Evaluating Clone Algo's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Clone Algo's pink sheet performance include:
  • Analyzing Clone Algo's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Clone Algo's stock is overvalued or undervalued compared to its peers.
  • Examining Clone Algo's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Clone Algo's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Clone Algo's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Clone Algo's pink sheet. These opinions can provide insight into Clone Algo's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Clone Algo's pink sheet performance is not an exact science, and many factors can impact Clone Algo's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Consideration for investing in Clone Pink Sheet

If you are still planning to invest in Clone Algo Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Clone Algo's history and understand the potential risks before investing.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Transaction History
View history of all your transactions and understand their impact on performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine